BTW, when asked about Ridaforolimus, sounded like Berger stumbled around answering questions about whats next for Ridaforolimus and didnt even mention endometrial cancers...all he said was breast cancer ie., their current Phase 2 trial...which is a long way from being completed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.